Skip to main content
. 2022 Sep 5;14(9):e28805. doi: 10.7759/cureus.28805

Table 1. Galectin-3 levels of the study groups.

*p-value derived from Kruskal-Wallis' test and refers to the comparison between whole the groups

**p-value is derived from the Mann-Whitney U test and refers to the comparison between control and moderate disease groups.

***p-value is derived from the Mann-Whitney U test and refers to the comparison between control and severe/critical disease groups.

****p-value is derived from the Mann-Whitney U test and refers to the comparison between moderate disease groups and severe/critical disease groups.

  Controls (N=50) Moderate Disease Group (N=40) Severe/Critical Disease Group (N=60) P-value
  Mean±SD Median (IQR) Mean±SD Median (IQR) Mean±SD Median (IQR)  
Galectin-3 15.78±10.8 13.57 (10.9-16.4) 12.58±5.34 13.52 (10.69-16.6) 9.95±5.15 11.65 (6.09-14.33) *p= 0.003  
**p= 0.548
***p= 0.001  
****p= 0.019